相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。POFUT1 promotes colorectal cancer development through the activation of Notch1 signaling
Yuheng Du et al.
CELL DEATH & DISEASE (2018)
Physical activity, mediating factors and risk of colon cancer: insights into adiposity and circulating biomarkers from the EPIC cohort
Krasimira Aleksandrova et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2017)
MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer
Yiying Wu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
microRNA-29c inhibits cell proliferation by targeting NASP in human gastric cancer
Beiqin Yu et al.
BMC CANCER (2017)
Rheb signaling and tumorigenesis: mTORC1 and new horizons
Marisol E. Armijo et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Rheb Promotes Cancer Cell Survival Through p27Kip1-Dependent Activation of Autophagy
Tania Campos et al.
MOLECULAR CARCINOGENESIS (2016)
Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis
Sandra Fernandes Martins et al.
BMC CANCER (2016)
A short interval between bevacizumab and anti-epithelial growth factor receptor therapy interferes with efficacy of subsequent anti-EGFR therapy for refractory colorectal cancer
Hiroya Taniguchi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2016)
Diet and Colorectal Cancer Risk in Asia - a Systematic Review
Salman Azeem et al.
Asian Pacific Journal of Cancer Prevention (2015)
Colorectal Cancer Screening and Surveillance in the Elderly: Updates and Controversies
Lukejohn W. Day et al.
GUT AND LIVER (2015)
Downregulation of angiogenin inhibits the growth and induces apoptosis in human bladder cancer cells through regulating AKT/mTOR signaling pathway
Jing Shu et al.
JOURNAL OF MOLECULAR HISTOLOGY (2015)
Sex- and gender-specific disparities in colorectal cancer risk
Sung-Eun Kim et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Rheb phosphorylation is involved in p38-regulated/activated protein kinase-mediated tumor suppression in liver cancer
Min Zheng et al.
ONCOLOGY LETTERS (2015)
Point mutations of the mTOR-RHEB pathway in renal cell carcinoma
Arindam P. Ghosh et al.
ONCOTARGET (2015)
PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance
Merritt P. Edlind et al.
ASIAN JOURNAL OF ANDROLOGY (2014)
Association between the IFN-γ and IL-1 genetic polymorphisms and colorectal cancer in the Chinese Han population
Bao-Ying Fei et al.
JOURNAL OF GENETICS (2014)
mTOR pathway in colorectal cancer: an update
Maria Giovanna Francipane et al.
ONCOTARGET (2014)
Early Detection of Colorectal Cancer Recurrence in Patients Undergoing Surgery with Curative Intent: Current Status and Challenges
Patrick. E. Young et al.
JOURNAL OF CANCER (2014)
Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies
Sandra Heskamp et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Mutations in Critical Domains Confer the Human mTOR Gene Strong Tumorigenicity
Avaniyapuram Kannan Murugan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Cellular Entry of Human Papillomavirus Type 16 Involves Activation of the Phosphatidylinositol 3-Kinase/Akt/mTOR Pathway and Inhibition of Autophagy
Zurab Surviladze et al.
JOURNAL OF VIROLOGY (2013)
Upregulation of Ras homolog enriched in the brain (Rheb) in lipopolysaccharide-induced neuroinflammation
Maohong Cao et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
Polyisoprenylated Methylated Protein Methyl Esterase Is Both Sensitive to Curcumin and Overexpressed in Colorectal Cancer: Implications for Chemoprevention and Treatment
Felix Amissah et al.
BIOMED RESEARCH INTERNATIONAL (2013)
mTOR Inhibition Prevents Epithelial Stem Cell Senescence and Protects from Radiation-Induced Mucositis
Ramiro Iglesias-Bartolome et al.
CELL STEM CELL (2012)
Aspirin Inhibits mTOR Signaling, Activates AMP-Activated Protein Kinase, and Induces Autophagy in Colorectal Cancer Cells
Farhat V. N. Din et al.
GASTROENTEROLOGY (2012)
Farnesylthiosalicylic acid (salirasib) inhibits Rheb in TSC2-null ELT3 cells: A potential treatment for lymphangioleiomyomatosis
Victoria Makovski et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Rheb/mTOR Activation and Regulation in Cancer: Novel Treatment Strategies beyond Rapamycin
Justin T. Babcock et al.
CURRENT DRUG TARGETS (2011)
Signaling circuitries controlling stem cell fate: to be or not to be
Ramiro Iglesias-Bartolome et al.
CURRENT OPINION IN CELL BIOLOGY (2011)
mTOR Signaling and Metabolic Regulation of T Cells: New Potential Therapeutic Targets in Autoimmune Diseases
Marina Pierdominici et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Surveillance after Curative Resection of Colorectal Cancer
Adena Scheer et al.
Clinics in Colon and Rectal Surgery (2009)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase
Yasemin Sancak et al.
MOLECULAR CELL (2007)
Complexity of the TOR signaling network
K Inoki et al.
TRENDS IN CELL BIOLOGY (2006)
TOR signaling in growth and metabolism
S Wullschleger et al.
CELL (2006)
TOR signaling in growth and metabolism
Stephan Wullschleger et al.
CELL (2006)
Rheb binds and regulates the mTOR kinase
X Long et al.
CURRENT BIOLOGY (2005)
Akt regulates growth by directly phosphorylating Tsc2
CJ Potter et al.
NATURE CELL BIOLOGY (2002)
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
K Inoki et al.
NATURE CELL BIOLOGY (2002)
PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers
XP Zhou et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-Kinase/Akt pathway
BD Manning et al.
MOLECULAR CELL (2002)
分享论文
